Cost of Revenue in USD of Vir Biotechnology, Inc. from 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Vir Biotechnology, Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to Q2 2025.
  • Vir Biotechnology, Inc. Cost of Revenue for the quarter ending June 30, 2025 was $11K, a 78.8% decline year-over-year.
  • Vir Biotechnology, Inc. Cost of Revenue for the twelve months ending June 30, 2025 was $745K, a 21.3% decline year-over-year.
  • Vir Biotechnology, Inc. annual Cost of Revenue for 2024 was $845K, a 69.4% decline from 2023.
  • Vir Biotechnology, Inc. annual Cost of Revenue for 2023 was $2.77M.
  • Vir Biotechnology, Inc. annual Cost of Revenue for 2022 was $146M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)

Vir Biotechnology, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $745K $11K -$41K -78.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $786K $0 -$59K -100% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $845K $684K -$114K -14.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $959K $50K +$12K +31.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $947K $52K +$30K +136% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $917K $59K -$1.85M -96.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $2.77M $798K Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $38K -$22.2M -99.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $22K -$27.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.91M -$88.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q3 2022 $131M $22.3M +$14.4M +184% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $117M $27.9M* +$26.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $90.2M $90.1M* +$90.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $65.9K -$8.91M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $7.84M +$7.84M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.14M +$1.14M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05

Vir Biotechnology, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $845K -$1.92M -69.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $2.77M -$144M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $146M* +$146M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $65.9K +$65.9K Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.